Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

Presentation TCT 2022

Safety and Performance of a Sirolimus Eluting Resorbable Coronary Magnesium Scaffold (DREAMS 3G): The BIOMAG-1 FIH Trial

Presenter: Michael Haude

September 19, 2022

Presentation TCT 2022

Scaffolds

Presenter: Brian G. DeRubertis

September 18, 2022

Presentation TCT 2022

Scaffolds Are Back: What's Old Is New

Presenter: Brian DeRubertis

September 18, 2022

Presentation TCT 2022

TCT 64: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – 3 Clinical Year Outcomes

Presenter: Matthias Lutz

September 17, 2022

Presentation TCT 2022

TCT 63: Long-term Outcomes of bioabsorbable magnesium scaffold in acute coronary syndromes

Presenter: Alejandro Gutierrez-Barrios

September 17, 2022

Presentation TCT 2022

TCT 62: Novel, Biodegradable PLA/PLGA Amorphous Polymer Scaffold In The Porcine Coronary Restenosis Model.

Presenter: Piotr Buszman

September 17, 2022

Presentation TCT 2022

TCT 61: Safety and efficacy of the Resorbable Magnesium Scaffold Magmaris in a Real-World Setting – 24-month Follow-up of the Full Cohort (2066 subjects) of the BIOSOLVE-IV Registry

Presenter: Johan Bennett

September 17, 2022

Presentation TCT 2022

TCT 52: Structural and Functional Evaluation of Coronary Arteries Treated With Absorb Bioresorbable Vascular Scaffold at 5-Year Follow-Up

Presenter: Luis Goncalves-Ramírez

September 17, 2022

Presentation TCT 2022

TCT 59: Impact of prolonged dual antiplatelet therapy duration on bioresorbable scaffolds outcomes: five-year data from a prospective registry.

Presenter: Giulia Masiero

September 17, 2022

Presentation TCT 2022

TCT 58: FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Final: 5 Year Clinical Outcomes

Presenter: Matthias Lutz

September 17, 2022

Presentation TCT 2022

TCT 57: Everolimus-eluting Bioresorbable Vascular Scaffolds for Coronary Atherosclerosis Restoration Therapy: Insights on Long-term Intracoronary Imaging and Physiological Results of Bioresorption

Presenter: Gabriele Pesarini

September 17, 2022

Presentation TCT 2022

TCT 56: Long-term outcomes after bioresorbable vascular scaffold implantation in patients with de-novo coronary artery disease.

Presenter: Marta Konopko

September 17, 2022

News Industry News

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

September 13, 2022

News Features

Aortic Valve Replacement: What’s on the Wish List for Future Devices?

Shelley Wood

March 14, 2022

News Conference News

BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years

Caitlin E. Cox

March 02, 2022

News Daily News

In-Hospital Stroke Requires a Rethink: AHA

Michael O'Riordan

February 09, 2022

Advertisement

Safety and Performance of a Sirolimus Eluting Resorbable Coronary Magnesium Scaffold (DREAMS 3G): The BIOMAG-1 FIH Trial

Scaffolds

Scaffolds Are Back: What's Old Is New

TCT 64: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – 3 Clinical Year Outcomes

TCT 63: Long-term Outcomes of bioabsorbable magnesium scaffold in acute coronary syndromes

TCT 62: Novel, Biodegradable PLA/PLGA Amorphous Polymer Scaffold In The Porcine Coronary Restenosis Model.

TCT 61: Safety and efficacy of the Resorbable Magnesium Scaffold Magmaris in a Real-World Setting – 24-month Follow-up of the Full Cohort (2066 subjects) of the BIOSOLVE-IV Registry

TCT 52: Structural and Functional Evaluation of Coronary Arteries Treated With Absorb Bioresorbable Vascular Scaffold at 5-Year Follow-Up

TCT 59: Impact of prolonged dual antiplatelet therapy duration on bioresorbable scaffolds outcomes: five-year data from a prospective registry.

TCT 58: FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Final: 5 Year Clinical Outcomes

TCT 57: Everolimus-eluting Bioresorbable Vascular Scaffolds for Coronary Atherosclerosis Restoration Therapy: Insights on Long-term Intracoronary Imaging and Physiological Results of Bioresorption

TCT 56: Long-term outcomes after bioresorbable vascular scaffold implantation in patients with de-novo coronary artery disease.

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

Aortic Valve Replacement: What’s on the Wish List for Future Devices?

BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years

In-Hospital Stroke Requires a Rethink: AHA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content